作者：
Calabresi,P.A. [1]
;
Radue,E.-W. [2]
;
Goodin,D. [3]
;
Jeffery,D. [4]
;
Rammohan,K.W. [5]
;
Reder,A.T. [6]
;
Vollmer,T. [7]
;
Agius,M.A. [8]
;
Kappos,L. [9]
;
Stites,T. [10]
;
Li,B. [11]
;
Cappiello,L. [12]
;
VonRosenstiel,P. ;
Lublin,F.D.
作者单位：
Department of Neurology, University of California, San Francisco, CA, United States
[1]
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[2]
Department of Neurology, University of Miami, Miami, FL, United States
[3]
Department of Neurology, University of Colorado Denver, Aurora, CO, United States
[4]
Multiple Sclerosis and Movement Disorders Center, Cornerstone Health Care, Winston-Salem, NC
[5]
Department of Neurology, University of California at Davis, Davis, CA, United States, Department of
[6]
Department of Neurology, University of Chicago Medical Center, Chicago, IL, United States
[7]
Novartis Pharma AG, Basel, Switzerland
[8]
Department of Neurology, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai
[9]
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
[10]
Department of Neurology, University Hospital, Basel, Switzerland
[11]
Medical Image Analysis Center, University Hospital, Basel, Switzerland
[12]
发布时间
2014-07-31
换一批
